ARTICLE | Clinical News
BMS-663068: Additional Phase IIb data
March 23, 2015 7:00 AM UTC
Additional data from the double-blind Phase IIb AI438011 trial in 251 evaluable treatment-experienced patients with HIV-1 infection showed that 61-82% of patients receiving BMS-663068 as an add-on to ...